JAVTX Mutual Fund

JAVTX Mutual Fund

NAV$87.32
See how much of JAVTX you already own
Just $25 once·$99/mo·Download sample
X-ray my portfolio free

Fund Essentials - as of Aug 31, 2026

Net Assets
$722M
Expense Ratio
0.92%
Dividend Yield (Current)
-
Holdings
143
Inception Date
Apr 30, 1985
Fund Family
Janus Henderson Investors
Investment Style
PRO
Asset Class
PRO
Legal Structure
PRO
Dividend Frequency
Annually

Performance

YTD+7.41%
1 Year+9.22%
3 Year+17.88%
5 Year+2.41%
10 Year+10.14%

Asset Allocation

Stocks: 96.66%
Other: 3.34%
See how much of JAVTX you already own
Your funds unpacked, overlap, fees and score, free on screen. The full report comes with FundXLS. Download sample.
X-ray my portfolio free

Top Holdings

View All →
TickerNameWeight
GKOSGlaukos Corp3.33%
LGNDLigand Pharmaceuticals Inc2.12%
PRMPerimeter Solutions Inc1.97%
SXTSensient Technologies Corp1.80%
SPXCSpx Corp1.79%
Top 10 Concentration: 19.33%Report Date: Aug 31, 2026
Download all 143 holdings for JAVTX
CSV export with sector, industry & share changes
Get CSV

Dividend Summary

View Details →
Frequency
Annually
Latest Distribution
$12.33
-

Peer Comparison

Benchmark
PRO
Peer outperformance: PRO
Category rank: PRO
This Mutual Fund
PRO
Peer Avg
PRO

JAVTX Mutual Fund Overview

JAVTX Mutual Fund (Janus Henderson Venture Fund Class T) is managed by Janus Henderson Investors with $722.4M in net assets. JAVTX expense ratio is 0.92%, holding 143 positions across sectors including Health Care, Information Technology, Industrials. Inception date: 1985-04-30.

JAVTX performance shows a YTD return of 7.41%. The 1-year return is 9.22% and the 5-year return is 2.41%.

JAVTX top holdings include Glaukos Corp (3.3%), Ligand Pharmaceuticals Inc (2.1%), Perimeter Solutions Inc (2.0%), Sensient Technologies Corp (1.8%), Spx Corp (1.8%). Go to all JAVTX holdings, JAVTX sectors, or JAVTX dividends.

JAVTX can be compared against other funds. Use JAVTX overlap to find shared positions, or JAVTX vs another fund for a side-by-side view. JAVTX alternatives are available via the screener, along with tax-loss harvesting opportunities.